导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 32.28% | 138/1050 |
| 近一周 | 1.39% | 148/1104 |
| 近一月 | -2.98% | 532/1103 |
| 近一季 | -15.53% | 873/1092 |
| 近半年 | 18.65% | 180/1070 |
| 近一年 | 22.99% | 219/1018 |
| 近两年 | 45.09% | 548/926 |
| 近三年 | 19.23% | 508/834 |
| 成立以来 | 61.96% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.89% 203/1070 |
82.50% 95/1101 |
- - |
- - |
| 2025 | -9.99% 960/1065 |
-8.82% 999/1014 |
-6.43% 986/1038 |
16.53% 712/1050 |
-9.47% 866/1065 |
| 2024 | 8.69% 321/1011 |
0.96% 266/960 |
-0.89% 370/983 |
10.68% 574/991 |
-1.85% 436/1011 |
| 2023 | -24.60% 770/952 |
-4.14% 777/880 |
-7.42% 660/895 |
-8.27% 517/915 |
-7.39% 716/952 |
| 2022 | -24.64% 483/867 |
-8.68% 80/773 |
-0.57% 707/806 |
-12.76% 443/845 |
-4.87% 646/867 |
| 2021 | 27.83% 87/740 |
1.45% 99/580 |
14.19% 252/659 |
6.29% 101/704 |
3.81% 270/740 |
| 2020 | 85.52% 74/554 |
0.83% 145/419 |
28.99% 137/466 |
9.47% 263/517 |
30.30% 39/554 |
| 2019 | 47.66% 168/410 |
25.87% 641/1146 |
-6.19% 787/1228 |
13.98% 51/390 |
9.72% 168/410 |
| 2018 | -25.50% 156/349 |
- - |
-5.57% 196/990 |
-10.01% 760/1000 |
-12.02% 583/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 建信中国制造2025股票A VS. 东吴新产业精选股票A(580008) |